Evidence map›Paper›PMID 29946024›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Sex-chromosome dosage effects on gene expression in humans.

Armin Raznahan, Neelroop N Parikshak, Vijay Chandran, Jonathan D Blumenthal, Liv S Clasen, Aaron F Alexander-Bloch, Andrew R Zinn, Danny Wangsa, Jasen Wise, Declan G M Murphy and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Transcriptomic Convergence and the Female Protective Effect in Autism.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. X and Y gene dosage effects are primary contributors to human sexual dimorphism: The case of height.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 2 countries.

Armin RaznahanDevelopmental Neurogenomics Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892; raznahana@mail.nih.gov.
Neelroop N ParikshakNeurogenetics Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Vijay ChandranDepartment of Pediatrics, School of Medicine, University of Florida, Gainesville, FL 32610.
Jonathan D BlumenthalDevelopmental Neurogenomics Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892.
Liv S ClasenDevelopmental Neurogenomics Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892.
Aaron F Alexander-BlochDevelopmental Neurogenomics Unit, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892.
Andrew R ZinnMcDermott Center for Human Growth and Development, University of Texas Southwestern Medical School, Dallas, TX 75390.
Danny WangsaGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Jasen WiseQiagen, Frederick, MD 21703.
Declan G M MurphyInstitute of Psychiatry, Psychology and Neuroscience, King's College London, University of London, London WC1B 5DN, United Kingdom.
Patrick F BoltonInstitute of Psychiatry, Psychology and Neuroscience, King's College London, University of London, London WC1B 5DN, United Kingdom.
Thomas RiedGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Judith RossDepartment of Pediatrics, Thomas Jefferson University, Philadelphia, PA 19107.
Jay N GieddDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093.
Daniel H GeschwindNeurogenetics Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
National Institute of Mental Health · USCenter for Autism and Related Disorders · USKing's College London · GBNational Institutes of Health · USCenter for Cancer Research · USQiagen (United States) · USThe University of Texas Southwestern Medical Center · USThomas Jefferson University · USUniversity of California, San Diego · USUniversity of Florida · US

Funding

Section on Developmental NeurogenomicsZIAMH002949 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI RAZNAHAN, ARMIN · 2016 to 2025
$30.0M
Medical Research Council MR/N026063/1
6 · The paper itself

Abstract

A fundamental question in the biology of sex differences has eluded direct study in humans: How does sex-chromosome dosage (SCD) shape genome function? To address this, we developed a systematic map of SCD effects on gene function by analyzing genome-wide expression data in humans with diverse sex-chromosome aneuploidies (XO, XXX, XXY, XYY, and XXYY). For sex chromosomes, we demonstrate a pattern of obligate dosage sensitivity among evolutionarily preserved X-Y homologs and update prevailing theoretical models for SCD compensation by detecting X-linked genes that increase expression with decreasing X- and/or Y-chromosome dosage. We further show that SCD-sensitive sex-chromosome genes regulate specific coexpression networks of SCD-sensitive autosomal genes with critical cellular functions and a demonstrable potential to mediate previously documented SCD effects on disease. These gene coexpression results converge with analysis of transcription factor binding site enrichment and measures of gene expression in murine knockout models to spotlight the dosage-sensitive X-linked transcription factor ZFX as a key mediator of SCD effects on wider genome expression. Our findings characterize the effects of SCD broadly across the genome, with potential implications for human phenotypic variation.

Indexed as

AneuploidyChromosomes, Human, XChromosomes, Human, YGene DosageGene Expression RegulationKruppel-Like Transcription FactorsModels, GeneticAnimalsFemaleGenome-Wide Association StudyHumansMaleMiceMice, KnockoutKruppel-Like Transcription Factorszinc finger protein, X-linkedKlinefelter syndromesex chromosomessex differencesTurner syndromeX-inactivation

Identifiers

PMID29946024
PMCPMC6048519
OpenAlexW2949507537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.